Mark W. Reynolds
2012
In 2012, Mark W. Reynolds earned a total compensation of $234.7K as Chief Financial Officer at GeoVax Labs, a 3% decrease compared to previous year.
Compensation breakdown
| Option Awards | $13,875 |
|---|---|
| Salary | $212,600 |
| Other | $8,238 |
| Total | $234,713 |
Reynolds received $212.6K in salary, accounting for 91% of the total pay in 2012.
Reynolds also received $13.9K in option awards and $8.2K in other compensation.
Rankings
In 2012, Mark W. Reynolds' compensation ranked 10,631st out of 11,487 executives tracked by ExecPay. In other words, Reynolds earned more than 7.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,631 out of 11,487 | 8th |
Division Manufacturing | 3,951 out of 4,253 | 7th |
Major group Chemicals And Allied Products | 1,104 out of 1,198 | 8th |
Industry group Drugs | 848 out of 920 | 8th |
Industry Pharmaceutical Preparations | 645 out of 700 | 8th |
Source: SEC filing on April 23, 2013.
Reynolds' colleagues
We found two more compensation records of executives who worked with Mark W. Reynolds at GeoVax Labs in 2012.